Summary
The 2022 ESC/ERS pulmonary hypertension guidelines represent a systematic synthesis of available evidence to support clinical decision-making in the diagnosis and management of pulmonary hypertension. These recommendations are designed for use by health professionals in routine clinical practice, with explicit acknowledgement that individualised clinical judgement remains essential for patient care. The guidelines incorporate contemporary clinical management adaptations reflecting evolving understanding of the condition.
UK applicability
These European Society of Cardiology and European Respiratory Society guidelines are directly applicable to United Kingdom clinical practice, as they represent multinational consensus guidance adopted across European healthcare systems. UK clinicians managing pulmonary hypertension would typically reference these guidelines for evidence-based diagnostic and therapeutic strategies.
Key measures
Clinical management strategies, diagnostic approaches, evidence synthesis and recommendations for pulmonary hypertension care
Outcomes reported
The guidelines provide synthesised evidence-based recommendations for diagnosis and clinical management of pulmonary hypertension across diverse patient presentations. The document aims to standardise decision-making approaches for health professionals managing individuals with pulmonary hypertension.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.